EVA Therapeutics, Inc. develops Enteral Ventilation Technology named as EVA for intra-rectal delivery of a liquid form of O2 (oxygen) with perfluorocarbon.
A new and inspiring video about Enteral Ventilation (EVA); a highly promising technology that may enable the treatment of diseases caused by systemic hypoxia through localized organ oxygenation.
#EVA#evangelion
https://t.co/McW6d68Q3f
The founder of EVA Therapeutics, Inc., Takanori Takebe, MD, PhD, has been named to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.
https://t.co/K7sbOjNUZg
EVA Therapeutics will host a booth to introduce its core technology Enteral Ventilation to save the lives of preterm babies at Tech Ōsaka Summit on Sep 16 & 17
https://t.co/OWvKnRyWuS
#Osaka2025